LPL Financial’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.16M Buy
13,091
+7,717
+144% +$1.86M ﹤0.01% 2682
2025
Q1
$1.31M Buy
5,374
+179
+3% +$43.6K ﹤0.01% 3289
2024
Q4
$1.71M Buy
5,195
+1,326
+34% +$436K ﹤0.01% 2990
2024
Q3
$1.29M Buy
3,869
+527
+16% +$176K ﹤0.01% 3109
2024
Q2
$913K Sell
3,342
-711
-18% -$194K ﹤0.01% 3301
2024
Q1
$1.4M Sell
4,053
-20,864
-84% -$7.22M ﹤0.01% 2856
2023
Q4
$8.05M Sell
24,917
-7,420
-23% -$2.4M ﹤0.01% 1374
2023
Q3
$11.6M Buy
32,337
+1,486
+5% +$533K 0.01% 1076
2023
Q2
$11.7M Buy
30,851
+1,600
+5% +$607K 0.01% 1053
2023
Q1
$14M Buy
29,251
+1,328
+5% +$636K 0.01% 913
2022
Q4
$11.7M Sell
27,923
-61
-0.2% -$25.6K 0.01% 942
2022
Q3
$11.7M Buy
27,984
+1,604
+6% +$669K 0.01% 879
2022
Q2
$13.1M Buy
26,380
+1,607
+6% +$795K 0.01% 830
2022
Q1
$14M Buy
24,773
+799
+3% +$450K 0.01% 815
2021
Q4
$18.1M Buy
23,974
+2,986
+14% +$2.26M 0.02% 720
2021
Q3
$15.7M Sell
20,988
-936
-4% -$698K 0.01% 729
2021
Q2
$14.1M Buy
21,924
+1,762
+9% +$1.14M 0.01% 735
2021
Q1
$11.5M Buy
20,162
+2,915
+17% +$1.66M 0.01% 759
2020
Q4
$10.1M Buy
17,247
+2,637
+18% +$1.54M 0.01% 741
2020
Q3
$7.53M Buy
14,610
+1,940
+15% +$1M 0.01% 752
2020
Q2
$5.72M Buy
12,670
+2,472
+24% +$1.12M 0.01% 807
2020
Q1
$3.58M Buy
10,198
+820
+9% +$287K 0.01% 888
2019
Q4
$3.47M Buy
9,378
+973
+12% +$360K 0.01% 1015
2019
Q3
$2.8M Buy
8,405
+691
+9% +$230K 0.01% 1060
2019
Q2
$2.41M Buy
7,714
+1,763
+30% +$551K 0.01% 1145
2019
Q1
$1.82M Buy
5,951
+966
+19% +$295K ﹤0.01% 1239
2018
Q4
$1.16M Buy
4,985
+591
+13% +$137K ﹤0.01% 1414
2018
Q3
$1.38M Buy
4,394
+519
+13% +$162K ﹤0.01% 1429
2018
Q2
$1.12M Sell
3,875
-568
-13% -$164K ﹤0.01% 1540
2018
Q1
$1.11M Buy
4,443
+1,074
+32% +$269K ﹤0.01% 1512
2017
Q4
$804K Buy
3,369
+68
+2% +$16.2K ﹤0.01% 1685
2017
Q3
$734K Buy
+3,301
New +$734K ﹤0.01% 1647